Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lei Dou

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Cell Death & Disease|September 14, 2023
HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathwayTao Han, Tingsong Chen, Lujun Chen, et al.
Oncology Reports|December 10, 2015
Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascadeBinhao Zhang, Chao Leng, Chao Wu, et al.
Molecular & Cellular Proteomics : MCP|November 14, 2008
Bayesian nonparametric model for the validation of peptide identification in shotgun proteomicsJiyang Zhang, Jie Ma, Lei Dou, et al.
Frontiers in Oncology|August 8, 2022
Cost-effectiveness analysis of nivolumab combination therapy in the first-line treatment for advanced esophageal squamous-cell carcinomaShixian Liu, Lei Dou, Kaixuan Wang, et al.
ACS Biomaterials Science & Engineering|December 15, 2020
3-D Human Renal Tubular Organoids Generated from Urine-Derived Stem Cells for Nephrotoxicity ScreeningHaibin Guo, Nan Deng, Lei Dou, et al.
International Journal of Clinical and Experimental Pathology|August 12, 2015
Unfolded protein response mediated JNK/AP-1 signal transduction, a target for ovarian cancer treatmentGao-Feng Zheng, Zhen Cai, Xiang-Kai Meng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 12, 2022
Corrigendum to "Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer" [Journal of Controlled Release 349 (2022) 876-889]Lei Dou, Huiqin Liu, Kaixin Wang, et al.
Foods (Basel, Switzerland)|July 29, 2025
Dihydromyricetin/Protein Pickering Emulsions: Interfacial Behavior, Rheology, and <i>In Vitro</i> BioaccessibilityShengqi Mei, Lei Dou, Kaixuan Cheng, et al.
Annals of the Rheumatic Diseases|March 26, 2022
Pilot study of baricitinib for active Sjogren's syndromeWei Bai, Huilan Liu, Lei Dou, et al.
Biomedical Chromatography : BMC|June 15, 2021
Pharmacokinetics, bioavailability and metabolism of neferine in rat by LC-MS/MS and LC-HRMSLin Hu, Yu Wang, Chang Shu, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Cell Death & Disease|September 14, 2023
HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathwayTao Han, Tingsong Chen, Lujun Chen, et al.
Oncology Reports|December 10, 2015
Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascadeBinhao Zhang, Chao Leng, Chao Wu, et al.
Molecular & Cellular Proteomics : MCP|November 14, 2008
Bayesian nonparametric model for the validation of peptide identification in shotgun proteomicsJiyang Zhang, Jie Ma, Lei Dou, et al.
Frontiers in Oncology|August 8, 2022
Cost-effectiveness analysis of nivolumab combination therapy in the first-line treatment for advanced esophageal squamous-cell carcinomaShixian Liu, Lei Dou, Kaixuan Wang, et al.
ACS Biomaterials Science & Engineering|December 15, 2020
3-D Human Renal Tubular Organoids Generated from Urine-Derived Stem Cells for Nephrotoxicity ScreeningHaibin Guo, Nan Deng, Lei Dou, et al.
International Journal of Clinical and Experimental Pathology|August 12, 2015
Unfolded protein response mediated JNK/AP-1 signal transduction, a target for ovarian cancer treatmentGao-Feng Zheng, Zhen Cai, Xiang-Kai Meng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 12, 2022
Corrigendum to "Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer" [Journal of Controlled Release 349 (2022) 876-889]Lei Dou, Huiqin Liu, Kaixin Wang, et al.
Foods (Basel, Switzerland)|July 29, 2025
Dihydromyricetin/Protein Pickering Emulsions: Interfacial Behavior, Rheology, and <i>In Vitro</i> BioaccessibilityShengqi Mei, Lei Dou, Kaixuan Cheng, et al.
Annals of the Rheumatic Diseases|March 26, 2022
Pilot study of baricitinib for active Sjogren's syndromeWei Bai, Huilan Liu, Lei Dou, et al.
Biomedical Chromatography : BMC|June 15, 2021
Pharmacokinetics, bioavailability and metabolism of neferine in rat by LC-MS/MS and LC-HRMSLin Hu, Yu Wang, Chang Shu, et al.
Pageof 14